Related Experiment Video
Updated: May 25, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Review of cerebral microangiopathy and Alzheimer's disease: relation between white matter hyperintensities and
C Hommet1, K Mondon, T Constans
1Médecine Interne Gériatrique et CMRR, Hôpital Bretonneau, CHRU Tours, Tours, France. hommet@med.univ-tours.fr
Abstract:
Although Alzheimer's disease (AD) is basically considered to be a neurodegenerative disorder, cerebrovascular disease is also involved. The role of vascular risk factors and vascular disease in the progression of AD remains incompletely understood. With the development of brain MRI, it is now possible to detect small-vessel disease, whose prevalence and severity increase with age. The first types of small-vessel disease to be described were white matter hyperintensities (WMHs). More recently, small areas of signal loss on T(2)*-weighted images, also called microbleeds (MBs), have been reported. Cerebral MBs are focal deposits of hemosiderin that indicate prior microhemorrhages around small vessels, related to either ruptured atherosclerotic microvessels or amyloid angiopathy. Consequently, using brain MRI for the detection of microangiopathy may prove useful to improve our understanding of the impact of the vascular burden in AD pathology. The relationship between microangiopathy and the clinical course of AD or the conversion of mild cognitive impairment to AD remains questionable in terms of cognitive or affective symptoms, particularly if we consider MBs.
Insights
Alzheimer's disease involves cerebrovascular issues. Brain MRI detects small-vessel disease like microbleeds, aiding understanding of vascular impact on Alzheimer's pathology.
Area of Science:
- Neurology
- Neuroimaging
- Gerontology
Background:
- Alzheimer's disease (AD) is primarily neurodegenerative but involves cerebrovascular disease.
- The impact of vascular risk factors on AD progression is not fully understood.
- Aging increases the prevalence and severity of small-vessel disease.
Purpose of the Study:
- To investigate the role of small-vessel disease, detected by brain MRI, in Alzheimer's disease pathology.
- To explore the utility of detecting microangiopathy for understanding vascular burden in AD.
- To examine the questionable relationship between microangiopathy and clinical/affective symptoms in AD.
Main Methods:
- Utilizing brain Magnetic Resonance Imaging (MRI) to detect signs of small-vessel disease.
- Identifying white matter hyperintensities (WMHs) as a type of small-vessel disease.
- Detecting cerebral microbleeds (MBs) on T(2)*-weighted images, indicating prior microhemorrhages.
Main Results:
- Brain MRI enables detection of small-vessel disease, including WMHs and MBs, which are age-related.
- Cerebral MBs signify microhemorrhages linked to microvascular rupture or amyloid angiopathy.
- The precise relationship between microangiopathy and cognitive/affective symptoms in AD remains unclear.
Conclusions:
- Brain MRI is a valuable tool for detecting microangiopathy in the context of Alzheimer's disease.
- Understanding the vascular burden, including microbleeds, may improve insights into AD pathology.
- Further research is needed to clarify the link between microangiopathy and the clinical course of AD.
More Related Videos
Related Concept Videos
Dementia l: Introduction
Cerebral Edema ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Hemorrhagic Stroke ll: Pathophysiology

